Arnold And Itkin
Uncategorized |
Uncategorized
Houston, TX 77345
Recent News About Arnold And Itkin
View More
-
PHILADELPHIA – Johnson & Johnson, which was recently hit with a staggering $8 billion punitive damages verdict at the end of a recent trial surrounding anti-psychotic drug Risperdal in Philadelphia, has filed motions to set it aside and call for a retrial – in addition to calling for the presiding judge to recuse himself from the case moving forward, alleging improper conduct like high-fives and pictures with jurors.
-
PHILADELPHIA – A plaintiff attorney in the punitive damages trial for Risperdal argued Friday that an independent biostatistician who reviewed the drug’s data for a reanalysis conducted in 2015, was in fact a former consultant for Johnson & Johnson who had worked on other litigation the company was involved in.
-
PHILADELPHIA – Johnson & Johnson did not market anti-psychotic drug Risperdal off-label to pediatricians and pediatric psychologists prior to receiving Food & Drug Administration approval, according to a senior official testifying in a trial meant to determine if the pharmaceutical giant will be penalized with punitive damages.
-
PHILADELPHIA – On the first day of a trial that could expose Johnson & Johnson to millions of dollars in punitive damages, the company moved for a mistrial after plaintiffs attorneys reminded jurors of its massive value but was denied.